Eye banking in the coronavirus disease 2019 era
Related Experiment Video
Updated: Dec 13, 2025

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
Published on: May 25, 2022
1Department of Ophthalmology and Visual Sciences, W. K. Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, USA.
Purpose Of Review:
Coronavirus disease 2019, caused by novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is highly infectious; however, the different routes of transmission are not well understood. Transmission through tissue transplantation is possible and must be considered. This review will evaluate the current literature regarding routes of transmission, the likelihood of transmission through ocular tissue transplantation, and the guidelines in place to mitigate this risk.
Recent Findings:
Although respiratory droplets have been the primary route of SARS-CoV-2 transmission, there is evidence that transmission through blood donation and organ or tissue transplantation is possible. This includes corneal transplantation, as SARS-CoV-2 has been detected in conjunctival swabs of infected patients, and the ocular surface may play an important role in viral entry. Several tissue transplantation organizations have guidelines in place regarding the screening of donors and tissue procurement procedures, including clinical and/or PCR screening of donors. The Eye Bank Association of America (EBAA) is currently not recommending asymptomatic PCR screening. However, their antiseptic protocols may play an important role in viral inactivation.
Summary:
Based on the current literature and guidelines, the risk of SARS-CoV-2 transmission through corneal transplantation is likely low. However, tissue screening guidelines need to be re-evaluated regularly as knowledge regarding the SARS-CoV-2 virus evolves.
Insights
The risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission via corneal transplantation is low. However, ongoing evaluation of tissue screening guidelines is crucial as our understanding of SARS-CoV-2 evolves.
Area of Science:
- Virology
- Ophthalmology
- Infectious Diseases
Background:
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes Coronavirus disease 2019 (COVID-19), a highly infectious respiratory illness.
- While respiratory droplets are the primary transmission route, SARS-CoV-2 transmission via blood and tissue transplantation is a potential concern.
Purpose of the Study:
- To review current literature on SARS-CoV-2 transmission routes.
- To assess the risk of SARS-CoV-2 transmission through ocular tissue transplantation, specifically corneal transplants.
- To evaluate existing guidelines for mitigating transmission risk in tissue transplantation.
Main Methods:
- Literature review of scientific articles and transplantation guidelines.
- Analysis of evidence for SARS-CoV-2 presence in ocular tissues and potential for transmission.
- Examination of donor screening and tissue procurement procedures.
Main Results:
- SARS-CoV-2 has been detected in conjunctival swabs, suggesting the ocular surface may be involved in viral entry.
- While possible, evidence indicates a low risk of SARS-CoV-2 transmission through corneal transplantation.
- Existing guidelines include donor screening (clinical/PCR), though the Eye Bank Association of America does not currently recommend asymptomatic PCR screening.
Conclusions:
- The risk of SARS-CoV-2 transmission via corneal transplantation appears low based on current data.
- Antiseptic protocols in tissue procurement may contribute to viral inactivation.
- Continuous re-evaluation of tissue screening guidelines is necessary as knowledge of SARS-CoV-2 advances.
More Related Videos
10:14Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
09:03Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
Related Concept Videos
Glaucoma: Overview
Accessory Structures of the Eye
Angle Closure Glaucoma: Treatment
Anatomy of the Eyeball
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...